These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16601567)

  • 1. Involvement of the renin-angiotensin system in migraine.
    Tronvik E; Stovner LJ; Schrader H; Bovim G
    J Hypertens Suppl; 2006 Mar; 24(1):S139-43. PubMed ID: 16601567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
    Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
    Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
    Giles TD
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin system.
    Kurtz TW; Pravenec M
    Am J Hypertens; 2008 Aug; 21(8):852-9. PubMed ID: 18535538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
    Zografos T; Katritsis DG
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1270-85. PubMed ID: 20636314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial.
    Maione A; Nicolucci A; Craig JC; Tognoni G; Moschetta A; Palasciano G; Pugliese G; Procaccini DA; Gesualdo L; Pellegrini F; Strippoli GF;
    J Nephrol; 2007; 20(6):646-55. PubMed ID: 18046666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-diabetic effect of blockade of the renin-angiotensin system.
    Ando K; Fujita T
    Diabetes Obes Metab; 2006 Jul; 8(4):396-403. PubMed ID: 16776746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension.
    Tocci G; Sciarretta S; Facciolo C; Volpe M
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis.
    Ripa P; Ornello R; Pistoia F; Carolei A; Sacco S
    Expert Rev Neurother; 2014 Sep; 14(9):1043-55. PubMed ID: 25115162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
    Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
    Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-Angiotensin-Aldosterone System and Migraine: A Systematic Review of Human Studies.
    Sassi KLM; Martins LB; de Miranda AS; Teixeira AL
    Protein Pept Lett; 2020; 27(6):512-519. PubMed ID: 31995000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy to reduce cardiovascular events in high-risk patients: part 2.
    Bommer WJ
    Prev Cardiol; 2008; 11(4):215-22. PubMed ID: 19476574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M; Franchini M; Fanos V
    Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical approach in regression of glomerulosclerosis.
    Stoian M; Radulian G; Chiţac D; Simion E; Stoica V
    Rom J Intern Med; 2007; 45(2):215-8. PubMed ID: 18333378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blockers and cerebral protection in stroke.
    Thöne-Reineke C; Steckelings UM; Unger T
    J Hypertens Suppl; 2006 Mar; 24(1):S115-21. PubMed ID: 16601564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.
    Tikellis C; Cooper ME; Thomas MC
    Int J Biochem Cell Biol; 2006; 38(5-6):737-51. PubMed ID: 16198140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
    Kolasinska-Malkowska K; Filipiak KJ; Gwizdala A; Tykarski A
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):759-71. PubMed ID: 18510491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.